Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/05/2003 | US20030102099 Nano-dispersed powders and methods for their manufacture |
06/05/2003 | US20030101995 Dry powder inhalation system for transpulmonary administration |
06/05/2003 | CA2563052A1 Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.02,11.0 4,9]-hexadeca-2(11)3,5,7,9-pentaene |
06/05/2003 | CA2468582A1 Materials and methods for making improved micelle compositions |
06/05/2003 | CA2468494A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists |
06/05/2003 | CA2468390A1 Treatment of wounds and compositions employed |
06/05/2003 | CA2468344A1 Methods and compositions for treating lesions of the respiratory epithelium |
06/05/2003 | CA2468250A1 Pharmaceutical composition for nasal absorption |
06/05/2003 | CA2468135A1 Ginger extract preparation |
06/05/2003 | CA2467677A1 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
06/05/2003 | CA2466863A1 Formulations for oral administration of cromolyn sodium |
06/05/2003 | CA2466816A1 Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel |
06/05/2003 | CA2466807A1 Pharmaceutical formulations comprising indolinone derivatives |
06/05/2003 | CA2466677A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
06/05/2003 | CA2460785A1 Process for preparing chewing gum containing a nutritional supplement |
06/04/2003 | EP1316559A1 Adenosine derivatives and use thereof |
06/04/2003 | EP1316317A1 Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof |
06/04/2003 | EP1316316A1 Preparations for oral administration |
06/04/2003 | EP1316311A1 Therapeutic use on-demand of formoterol and budesonide |
06/04/2003 | EP1316310A1 Ophthalmic composition comprising a histidine derivative for healing asthenopia |
06/04/2003 | EP1316309A1 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
06/04/2003 | EP1316308A1 Transdermal therapeutic device with capsaicin and capsaicin analogs |
06/04/2003 | EP1316291A1 Great saphenous vein varix treatment tool |
06/04/2003 | EP1315968A2 Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof |
06/04/2003 | EP1315672A1 Delivery vehicle composition and methods for delivering antigens and other drugs |
06/04/2003 | EP1315537A1 Method and system for myocardial infarction repair |
06/04/2003 | EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
06/04/2003 | EP1315515A2 Method for treating schizophrenia and related psychoses, and the use of erythropoietin or erythropoietin derivatives for treating schizophrenic disorders and related psychoses |
06/04/2003 | EP1315514A2 Methods and compositions for producing a neurosalutary effect in a subject |
06/04/2003 | EP1315509A2 Treatment of drug resistant organisms with nitric oxide |
06/04/2003 | EP1315505A2 Pharmaceutical compositions for headache, migraine, nausea and emesis |
06/04/2003 | EP1315502A1 Method for treating erectile dysfunction and increasing libido in men |
06/04/2003 | EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
06/04/2003 | EP1315495A2 Use of threo-methylphenidate compounds to enhance memory |
06/04/2003 | EP1315487A2 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
06/04/2003 | EP1315484A1 Taxane-based compositions and methods of use |
06/04/2003 | EP1315482A2 Water-dispersible encapsulated sterols |
06/04/2003 | EP1315481A1 Medicament for treating intestinal diseases |
06/04/2003 | EP1315480A2 "slow release" pharmaceutical compositions comprising lithium carbonate |
06/04/2003 | EP1315479A1 Pectin film compositions |
06/04/2003 | EP1315478A2 Controlled release formulation of erythromycin or a derivative thereof |
06/04/2003 | EP1315477A1 Dry-powder film coating composition and method of preparation |
06/04/2003 | EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour |
06/04/2003 | EP1315474A2 Clear antiperspirants and deodorants made with siloxane-based polyamides |
06/04/2003 | EP1218016A4 Composition and method for producing lubricating, germicide foam |
06/04/2003 | EP1207857B1 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
06/04/2003 | EP1206248B1 Controlled-release sedative-hypnotic compositions and methods related thereto |
06/04/2003 | EP1198224B1 Formulations of steroid solutions for inhalatory administration |
06/04/2003 | EP1159061A4 Chemical method for making pyrithione particle dispersions |
06/04/2003 | EP1158960B1 Modified carrier particles for use in dry powder inhalers |
06/04/2003 | EP1156790B1 Combinations of formoterol and mometasone furoate |
06/04/2003 | EP1143934B1 Genetic immunization with co-delivery of nucleic acid and cytokines |
06/04/2003 | EP1143928B1 Milling process for the production of finely milled medicinal substances |
06/04/2003 | EP1119347A4 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
06/04/2003 | EP1097270B1 Use of pit emulsions |
06/04/2003 | EP1076671B1 Non cross-linked block polyetherester, preparation and uses |
06/04/2003 | EP1030676A4 Bonding of cartilaginous matrices using isolated chondrocytes |
06/04/2003 | EP1013734B1 Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same |
06/04/2003 | EP0977557B1 Pellet-type formulation intended for treating the intestinal tract |
06/04/2003 | EP0969821B1 Pellets having a core coated with an antifungal and a polymer |
06/04/2003 | EP0936874B1 Chewing gums and method of manufacturing the same |
06/04/2003 | EP0932394B1 Vitamin product |
06/04/2003 | EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration |
06/04/2003 | EP0920869B1 Stable external preparations containing acetylsalicylic acid |
06/04/2003 | EP0909175B1 Non-aqueous protic peptide formulations |
06/04/2003 | EP0885010B1 Intercellular adhesion molecule powder formulation |
06/04/2003 | EP0858324B1 Process for aqueous granulation of clarithromycin |
06/04/2003 | EP0814839B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
06/04/2003 | EP0744941B1 Process for preparing fine particle pharmaceutical formulations |
06/04/2003 | EP0689438B1 Pharmaceutical compositions for intranasal administration of apomorphine |
06/04/2003 | CN1422291A Process of microgel synthesis and products produced therefrom |
06/04/2003 | CN1422230A Infusion packet with useful and decorative element, support member, delivery system and method |
06/04/2003 | CN1422164A Preparations for preventing bile acid diarrhea |
06/04/2003 | CN1422163A Formulation solubilizing water-insoluble agents and preparation method thereof |
06/04/2003 | CN1422160A Nasal calcitonin formulations |
06/04/2003 | CN1422154A The treatment of respiratory diseases |
06/04/2003 | CN1422151A Pharmaceutical composition comprising fluvastatin |
06/04/2003 | CN1422150A Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine |
06/04/2003 | CN1422149A Pharmaceutical compositions |
06/04/2003 | CN1422148A Method for treating dry eye |
06/04/2003 | CN1422142A Pharmaceutical composition |
06/04/2003 | CN1422121A Protein stabilised emulsions |
06/04/2003 | CN1421246A Recombinant human insulin compound, its prepn and medicine composition containing the compound |
06/04/2003 | CN1421242A Compound red sage capsule for treating cardiac and cerebral vascular diseases and its prepn process |
06/04/2003 | CN1421241A Compound red sage drip pill for treating cardiac and cerebral vascular diseases and its prepn process |
06/04/2003 | CN1421230A Granulation promoting and pus drawing out ointment |
06/04/2003 | CN1421228A Tea, medicated tea and buccal tablet for lowering blood pressure and reducing blood fat and their prepn process |
06/04/2003 | CN1421223A Chinese patent medicine for treating hypertension, hyperlipemia and cardiac and cerebral vascular diseases |
06/04/2003 | CN1421208A Compound prepn containing alpha-linolic acid, lecithin and ginkgetin |
06/04/2003 | CN1421207A Control released osmotic pump prepn containing ligustrazine phosphate and its prepn process |
06/04/2003 | CN1421206A Medical composition |
06/04/2003 | CN1421200A Beriberi treating plaster with non-woven viscose fabric |
06/04/2003 | CN1421199A Veterinary emulsion injection containing parasiticide prepared via micropowder crystallization process |
06/04/2003 | CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof |
06/04/2003 | CN1110473C Method for removing contaminants from products |
06/04/2003 | CN1110327C Novel device for transdermal administration of trimegestone |
06/04/2003 | CN1110323C Rotavirus resisting immune globulin composition and its producing process and use |
06/04/2003 | CN1110321C Enteric insulin capsule for treating diabetes |
06/04/2003 | CN1110316C Black plaster and preparing process thereof |
06/04/2003 | CN1110304C Slow-release medicine composition for oral administration containing nifedipine as active substance |